Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-001169
Filing Date
2025-07-11
Accepted
2025-07-11 09:55:33
Documents
42
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acbm_10q.htm   iXBRL 10-Q 556140
2 CERTIFICATION acbm_ex311.htm EX-31.1 13878
3 CERTIFICATION acbm_ex321.htm EX-32.1 5698
  Complete submission text file 0001640334-25-001169.txt   2069647

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acbm-20230930.xsd EX-101.SCH 23373
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acbm-20230930_lab.xml EX-101.LAB 136169
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acbm-20230930_cal.xml EX-101.CAL 30109
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acbm-20230930_pre.xml EX-101.PRE 106720
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acbm-20230930_def.xml EX-101.DEF 42074
45 EXTRACTED XBRL INSTANCE DOCUMENT acbm_10q_htm.xml XML 187296
Mailing Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038
Business Address 12175 VISIONARY WAY SUITE 1160 FISHERS IN 46038 (317) 286-6788
ACRO BIOMEDICAL CO., LTD. (Filer) CIK: 0001622996 (see all company filings)

EIN.: 471950356 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55643 | Film No.: 251117725
SIC: 7900 Services-Amusement & Recreation Services
(CF Office: 07 Trade & Services)